In this episode, Hall welcomes Eyal Lifschitz, Co-Founder & General Managing Partner at Peregrine Ventures.
Peregrine Ventures is Israel’s leading venture capital fund and they invest in promising early-stage high-tech companies with a strong emphasis on Life Sciences, Digital Health and Information Technology.
Eyal has been an entrepreneur since the ’90s and prior to founding Peregrine Ventures, he co-founded and led the business development efforts of a number of medical technology companies including PharmaSys (acquired by Elan Corp. NYSE:ELN), ECR (acquired by AVX Corp. NYSE:AVX), Visioncare Ophthalmic Technologies, and BioControl Ltd. From 2003-2007 Eyal also served as a Director of Given Imaging (NASDAQ: GIVN).
Eyal speaks at length about robotics in the field and he is very excited about medical devices. He gives insight into the evolution of the industry, his fund’s investment thesis, and he advises both entrepreneurs and investors.
You can visit Peregrine Ventures at www.Peregrinevc.com.
Eyal can be contacted via LinkedIn at https://www.linkedin.com/in/eyal-lifschitz-459285134/ and via email at email@example.com.
Copyright (c) 2022, Hall Martin and investorconnect.org. All rights reserved.
Hall T Martin is the director of Investor Connect, which is a 501(c)(3) nonprofit dedicated to the education of investors for early-stage funding. All opinions expressed by Hall and podcast guests are solely their own opinions and do not reflect the opinion of Investor Connect. This podcast is for informational purposes only and should not be relied upon for the basis of investment decisions.